Mirtazapine versus selective serotonin reuptake inhibitors

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 17, 1999, Pages 18-22

  Thompson, Christopher ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RATING SCALE; SOMNOLENCE; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; CITALOPRAM; CLINICAL TRIALS; DEPRESSIVE DISORDER; FLUOXETINE; HUMANS; MIANSERIN; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0032841611     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. de Boer T. The pharmacologic profile of mirtazapine. J Clin Psychiatry 1996;57(suppl 4):19-25
2. de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol 1995;10(suppl 4): 19-23
3. Kasper S, Praschak-Rieder N, Tauscher J, et al. A risk-benefit assessment of mirtazapine in the treatment of depression. Drug Saf 1997;17:251-264
4. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995;10:39-47
5. Wheatley DP, van Moffaert M, Timmerman L, et al. Mirtazapine efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe depressive disorder. J Clin Psychiatry 1998;59:306-312
6. Agren H, Leinonen E, Skarstein J, et al. Efficacy and tolerability of mirtazapine vs citalopram: a double-blind, randomized study in patients with major depressive disorder [abstract]. In: Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology; Dec. 14-18, 1998; Las Croabas, Puerto Rico: 320
7. Benkert O, Szegedi A, Kohnen R. Rapid onset of therapeutic action in major depression: a comparative trial of mirtazapine and paroxetine [abstract]. In: Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology; Dec. 14-18, 1998; Las Croabas, Puerto Rico: 311
8. Phillip M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 1993;7:149-153